期刊文献+

Helicobacter pylori eradication and reflux disease onset:Did gastric acid get "crazy"? 被引量:4

Helicobacter pylori eradication and reflux disease onset:Did gastric acid get "crazy"?
下载PDF
导出
摘要 Gastroesophageal reflux disease (GORD) is highly prevalent in the general population.In the last decade,a potential relationship between Helicobacter pylori (H.pylori) eradication and GORD onset has been claimed.The main putative mechanism is the gastric acid hypersecretion that develops after bacterial cure in those patients with corpus-predominant gastritis.We performed a critical reappraisal of the intricate pathogenesis and clinical data available in this field.Oesophagitis onset after H.pylori eradication in duodenal ulcer patients has been ascribed to a gastric acid hypersecretion,which could develop following body gastritis healing.However,the absence of an acid hypersecretive status in these patients is documented by both pathophysiology and clinical studies.Indeed,duodenal ulcer recurrence is virtually abolished followingH.pylori eradication.In addition,intra-oesophageal pH recording studies failed to demonstrated increased acid reflux following bacterial eradication.Moreover,oesophageal manometric studies suggest that H.pylori eradication would reduce-rather than favor-acid reflux into the oesophagus.Finally,data of clinical studies would suggest that H.pylori eradication is not significantly associated with eitherreflux symptoms or erosive oesophagitis onset,some data suggesting also an advantage in curing the infection when oesophagitis is already present.Therefore,the legend of "crazy acid" remains-as all the others a fascinating,but imaginary tale. Gastroesophageal reflux disease (GORD) is highly prevalent in the general population. In the last decade, a potential relationship between Helicobacter pylori (H. pylori) eradication and GORD onset has been claimed. The main putative mechanism is the gastric acid hypersecretion that develops after bacterial cure in those patients with corpus-predominant gastritis. We performed a critical reappraisal of the intricate pathogenesis and clinical data available in this field. Oesophagitis onset after H. pylori eradication in duodenal ulcer patients has been ascribed to a gastric acid hypersecretion, which could develop following body gastritis healing. However, the absence of an acid hypersecretive status in these patients is documented by both pathophysiology and clinical studies. Indeed, duodenal ulcer recurrence is virtually abolished following H. pylori eradication. In addition, intra-oesophageal pH recording studies failed to demonstrated increased acid reflux following bacterial eradication. Moreover, oesophageal manometric studies suggest that H. pylori eradication would reduce - rather than favor - acid reflux into the oesophagus. Finally, data of clinical studies would suggest that H. pylori eradication is not significantly associated with either reflux symptoms or erosive oesophagitis onset, some data suggesting also an advantage in curing the infection when oesophagitis is already present. Therefore, the legend of “crazy acid” remains - as all the others - a fascinating, but imaginary tale.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第6期786-789,共4页 世界胃肠病学杂志(英文版)
关键词 HELICOBACTER pylori OESOPHAGEAL REFLUX OESOPHAGITIS ERADICATION PATHOPHYSIOLOGY Clinical studies Helicobacter pylori Oesophageal reflux Oesophagitis Eradication Pathophysiology Clinical studies
  • 相关文献

参考文献25

  • 1Lorenzo Fuccio,Leonardo Henry Eusebi,Franco Bazzoli.Gastric cancer, Helicobacter pylori infection and other risk factors[J].World Journal of Gastrointestinal Oncology,2010,2(9):342-347. 被引量:17
  • 2Angelo Zullo,Cesare Hassan,Francesca Cristofari,Francesco Perri,Sergio Morini.Gastric low-grade mucosal-associated lymphoid tissue-lymphoma: Helicobacter pylori and beyond[J].World Journal of Gastrointestinal Oncology,2010,2(4):181-186. 被引量:21
  • 3Tohko Shirota,Motoyasu Kusano,Osamu Kawamura,Tsutomu Horikoshi,Masatomo Mori,Toshikazu Sekiguchi.Helicobacter pylori infection correlates with severity of reflux esophagitis: with manometry findings[J]. Journal of Gastroenterology . 1999 (5)
  • 4Labenz J,Blum A L,Bayerdorffer E,et al.Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology . 1997
  • 5EL-Omer EM,DenmnID,ArdillJE,et al.Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology . 1995
  • 6Maconi G,Sainaghi M,Molteni M,et al.Predictors of long-term outcome of functional dyspepsia and duodenal ulcer after suc-cessful Helicobacter pylori eradication-a7-year follow-up study. European Journal of Gastroenterology and Hepatology . 2009
  • 7A Zullo,C Hassan,SMA Campo.Bleeding peptic ulcer in the elderly: risk factors and prevention strategies. Drugs and Aging . 2007
  • 8Weber C,Davis C S,Fisichella P M.Current applications of evolvingmethodologies in gastroesophageal reflux disease testing. Digestive and Liver Disease . 2011
  • 9Vakil N,van Zanten SV,Kahrilas Pet al.The Montreal definition and classification of gastroesophageal reflux disease:a global evi-dence-based consensus. The American journal of Gastroenterology . 2006
  • 10Pandolfino J E,,Kwiatek M A,Kahrilas P J.The pathophy-siologic basis for epidemiologic trends in gastroesophageal reflux disease. Gastroenterology Clinics of North America . 2008

二级参考文献103

  • 1Yong-ZhongWang You-QingCao Jian-NongWu MiaoChen Xiao-YingCha.Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA[J].World Journal of Gastroenterology,2005,11(1):46-50. 被引量:15
  • 2de Vries AC,Kuipers EJ,Rauws EA.Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn?The American journal of Gastroenterology,2009.
  • 3Parkin DM.Global cancer statistics in the year 2000The Lancet Oncology,2001.
  • 4Wong BC;Lam SK;Wong WM.Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China:a randomized controlled trial,2004(02).
  • 5Hussell T;Isaacson PG;Crabtree JE.The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori,1993.
  • 6Wotherspoon AC;Doglinoni C;Diss TC.Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of helicobacter pylori,1993.
  • 7Wotherspoon AC;Ortiz-Hidalgo C;Falzon MR;Isaacson PG.Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma,1991.
  • 8Tavassoli FA,Devilee P.World Health Organization classification of tumors, pathology and genetics of tumors of the breast and female genital organs,2003.
  • 9Kamangar F,Dores GM,Anderson WF.Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the worldJournal of Clinical Oncology,2006.
  • 10Malfertheiner P,Megraud F,O’Morain C,et al.Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut . 2007

共引文献36

同被引文献61

引证文献4

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部